Diana Ernst, RPh

The combination antibiotic consists of aztreonam, a monobactam β-lactam and avibactam, a broad-spectrum β-lactamase inhibitor.

Semaglutide, a GLP-1 receptor agonist, is currently approved under 3 brand names: Ozempic, Rybelsus, and Wegovy.

The approval was based on data from the LIGHTHOUSE and SPOTLIGHT clinical trials.

The is the first approval of an oral antiviral therapy for COVID-19.

Tradipitant is a neurokinin-1 receptor antagonist.

Xacduro is a co-packaged product containing sulbactam, a beta-lactam antibacterial and beta lactamase inhibitor, and durlobactam, a beta lactamase inhibitor.

This is the first FDA approval of nalmefene HCI in a nasal spray formulation.

Children who ingest the incorrect product are at increased risk of serious adverse events.

A regulatory decision is expected on June 22, 2023.

The Cyltezo Pen 40mg/0.8mL will be available on July 1, 2023.